MRVL

Marvell Technology, the semiconductor chip maker, generated strong Q1 FCF and FCF margins, and hiked its FY 2028 revenue forecast. That could raise its FCF forecast and MRVL's price target by 23%.

Barclays analyst Tom O'Malley maintains Marvell Technology (NASDAQ:MRVL) with a Overweight and raises the price target from $150 to $275.

Peace talk optimism and a parade of earnings results ranging from spectacular to sobering pushed all three major US indices to record highs on Thursday. One stock jumped 37%. Another quietly rewrote its own history after the close.

Marvell Technology has gained more than 200% in the past 12 months. It just reported record revenue, guided above expectations, and told investors that growth would accelerate every single quarter through the rest of the fiscal year. For Barclays analyst Tom O'Malley, that was enough to nearly ...

AI-related bookings pushed Marvell to raise revenue outlook as quarterly guidance topped estimates.

Marvell stock gains as robust Q1 earnings makes RBC raise its price target to $240. Here’s why the investment firm is bullish on MRVL shares.

Jim Cramer has been circling POET Technologies (NASDAQ:POET) for months, intrigued by the pitch but refusing to bite. On the April 21, 2026 episode of Mad Money, he walked through the optical interposer story, the Lighteon collaboration, even the Wolfpack Research short report and the CFO rebuttal, and landed where institutional money tends to land ... Jim Cramer Won’t Touch POET. The Reddit Crowd Thinks He’s Wrong. Somebody’s About to Lose a Lot of Money

UBS analyst Timothy Arcuri maintains Marvell Technology (NASDAQ:MRVL) with a Buy and raises the price target from $195 to $230.